Showing results (111-120 of 522) with videos related to
Sort By:
Pageof 53
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2015
A Long-Term Spinal Intramedullary Response to Ceritinib in ALK Rearranged Non-Small-Cell Lung CancerJosette Biya, Caroline Caramella, Colin R Lindsay, et al.Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation following administration of sunitinibAnaëlle Olivo, Nicolas Noël, Benjamin Besse, et al.Investigational New Drugs|February 20, 2016
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinibLinda Mahjoubi, Anas Gazzah, Benjamin Besse, et al.Progress in Retinal and Eye Research|September 20, 2024
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategiesEric E Gabison, Antoine Rousseau, Marc Labetoulle, et al.Nature Reviews. Clinical Oncology|August 16, 2018
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.Cancer Treatment Reviews|May 11, 2026
KRAS G12C-mutant non-small cell lung cancer: A practical guide for cliniciansJordi Remon, Giulia La-Cava, Maxime Borgeaud, et al.Bulletin Du Cancer|March 31, 2015
[Second generation ALK inhibitors in non-small cell lung cancer: systemic review]Marie Viala, Solenn Brosseau, David Planchard, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2019
Circulating Tumor DNA Analysis for Patients with Oncogene-Addicted NSCLC With Isolated Central Nervous System ProgressionMihaela Aldea, Lizza Hendriks, Laura Mezquita, et al.JTO Clinical and Research Reports|September 30, 2021
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief ReportDiego Enrico, Ludovic Lacroix, Jeanne Chen, et al.Pageof 53